BioWa and Lonza strike third licensing deal for mAb tech
BioWa and Lonza have agreed to license a cell line technology to antibody discovery company arGEN-X.
Archives for March 19, 2014
DISPATCHES FROM INTERPHEX 2014
'Podular' manufacturing to become facility norm within 5 years, say GEA and G-CON
‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility.
DISPATCHES FROM INTERPHEX
To QbD or not to QbD? For biologics it's a must says Cook Pharmica expert
The thorny issue of applying QbD to biopharmaceutical manufacture is a topic of hot debate at Interphex 2014 according to CMO Cook Pharmica.